发明公开
EP2275959A3 Method of screening a therapeutic agent for therapeutic effectiveness
审中-公开
的治疗剂的筛选方法以确定其有效性
- 专利标题： Method of screening a therapeutic agent for therapeutic effectiveness
- 专利标题（中）： 的治疗剂的筛选方法以确定其有效性
-
申请号： EP10183881.1申请日： 2002-07-11
-
公开(公告)号： EP2275959A3公开(公告)日： 2011-04-06
- 发明人: Suffin, Stephen , Emory, Hamlin W. , Brand, Leonard J.
- 申请人： CNS Response, Inc.
- 申请人地址： 2755 Bristol Street, Suite 285 Costa Mesa, CA 92626 US
- 专利权人： CNS Response, Inc.
- 当前专利权人： CNS Response, Inc.
- 当前专利权人地址： 2755 Bristol Street, Suite 285 Costa Mesa, CA 92626 US
- 代理机构： Glawe, Delfs, Moll
- 优先权： US304628P 20010711
- 主分类号： G06F19/00
- IPC分类号： G06F19/00 ; A61B5/04
摘要：
The present invention relates to a method of screening a therapeutic agent for therapeutic effectiveness, comprising:
a) providing:
i) at least one patient, wherein said patient has a first disorder associated with a first set of electroencephalographic information;
ii) a plurality of reference patients comprising at least one second disorder associated with a second set of electroencephalographic information;
iii) a therapeutic agent, wherein said agent has no known therapeutic effectiveness for said at least one second disorder; and
b) treating said patient with said agent, wherein said agent is therapeutically effective for said first disorder;
c) identifying, using a computer a similarity between said first set of electroencephalographic information and said second set of electroencephalographic information; and d. indicating said agent as having therapeutic effectiveness for said at least one second disorder based upon said similarity in said reference patients.
a) providing:
i) at least one patient, wherein said patient has a first disorder associated with a first set of electroencephalographic information;
ii) a plurality of reference patients comprising at least one second disorder associated with a second set of electroencephalographic information;
iii) a therapeutic agent, wherein said agent has no known therapeutic effectiveness for said at least one second disorder; and
b) treating said patient with said agent, wherein said agent is therapeutically effective for said first disorder;
c) identifying, using a computer a similarity between said first set of electroencephalographic information and said second set of electroencephalographic information; and d. indicating said agent as having therapeutic effectiveness for said at least one second disorder based upon said similarity in said reference patients.
公开/授权文献
信息查询
